BioSpace News Archive

Results from completed Phase 1b and ongoing Phase 2 trial of onvansertib in relapsed/refractory AML to be presented in oral session

Medical Marijuana, Inc. announced that its subsidiary Kannaway® was named Small Business Company of the Year in the Life Sciences, Health, Wellness, and Nutrition category by the Business Intelligence Group’s 2019 BIG Awards for Business.

Ion Torrent Genexus System* holds potential to advance precision medicine in the clinic

New data is from programs in B-cell non-Hodgkin lymphoma, multiple myeloma and paroxysmal nocturnal hemoglobinuria

New dynamic analyses of Phase 3 SIMPLIFY-1 transfusion data demonstrate that momelotinib patients are nearly 10-times more likely to remain transfusion free compared to ruxolitinib treated patients

Company’s Antibody Recruiting Molecules (ARMs) Demonstrated Strong Anti-Multiple Myeloma Activity In Multiple In Vivo Animal Models and Ex Vivo Against Patient Tumor Cells

Survival Data at Three Years in ZUMA-1 and Results from Study Cohort Evaluating Safety and Efficacy of Earlier Steroid Use with Yescarta® (axicabtagene ciloleucel) in Large B-cell Lymphoma to be Presented

ProtoKinetix, Incorporated is pleased to provide the following updates regarding upcoming news in key areas.

Data to be presented next month at the American Society of Hematology Annual Meeting

Xencor, Inc. announced that initial data from its ongoing Phase 1 dose-escalation study of XmAb®13676, a CD20 x CD3 bispecific antibody, in patients with B-cell malignancies will be presented in a poster session during the 61st American Society of Hematology Annual Meeting in Orlando, Florida on Monday, December 9, 2019.